UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

BCL-2 family isoforms in apoptosis and cancer

Cell death & disease, 2019-02, Vol.10 (3), p.177-177, Article 177

2019

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer

Cancers, 2021-11, Vol.13 (23), p.5993

2021

Link zum Volltext

Verfügbarkeit prüfen

Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy

BMC cancer, 2022-01, Vol.22 (1), p.100-100, Article 100

2022

Link zum Volltext

Verfügbarkeit prüfen

Methyl-Donor and Cofactor Nutrient Intakes in the First 2-3 Years and Global DNA Methylation at Age 4: A Prospective Cohort Study

Nutrients, 2018-02, Vol.10 (3), p.273

2018

Link zum Volltext

Verfügbarkeit prüfen

Low prevalence of germline PALB2 mutations in Australian triple‐negative breast cancer

International journal of cancer, 2014-01, Vol.134 (2), p.301-305

2014

Link zum Volltext

Verfügbarkeit prüfen

Global DNA methylation and cognitive and behavioral outcomes at 4 years of age: A cross‐sectional study

Brain and behavior, 2020-04, Vol.10 (4), p.e01579-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care

Journal of clinical oncology, 2016-05, Vol.34 (13), p.1455-1459

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

Breast cancer research : BCR, 2015-08, Vol.17 (1), p.111-111, Article 111

2015

Link zum Volltext

Verfügbarkeit prüfen

The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome

Carcinogenesis (New York), 2014-03, Vol.35 (3), p.586-596

2014

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer

Breast cancer research and treatment, 2015-02, Vol.150 (1), p.71-80

2015

Link zum Volltext

Verfügbarkeit prüfen

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study

NPJ breast cancer, 2021-06, Vol.7 (1), p.76-76, Article 76

2021

Link zum Volltext

Verfügbarkeit prüfen

Mutations in RECQL are not associated with breast cancer risk in an Australian population

Nature genetics, 2018-10, Vol.50 (10), p.1346-1348

2018

Link zum Volltext

Verfügbarkeit prüfen

The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome

Carcinogenesis (New York), 2016-01, Vol.37 (1), p.81-86

2016

Link zum Volltext

Verfügbarkeit prüfen

Fusobacterium nucleatum : An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers

Cells (Basel, Switzerland), 2024-04, Vol.13 (8), p.717

2024

Link zum Volltext

Verfügbarkeit prüfen

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context

Scientific reports, 2015-10, Vol.5 (1), p.14800-14800, Article 14800

2015

Link zum Volltext

Verfügbarkeit prüfen

Reevaluation of RINT1 as a breast cancer predisposition gene

Breast cancer research and treatment, 2016-09, Vol.159 (2), p.385-392

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans

Hereditary cancer in clinical practice, 2022-05, Vol.20 (1), p.20-20, Article 20

2022

Link zum Volltext

Verfügbarkeit prüfen

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015

Hereditary cancer in clinical practice, 2017-10, Vol.15 (S1), p.1-5

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel genes associated with lymph node metastasis in triple negative breast cancer

Scientific reports, 2015-11, Vol.5 (1), p.15832-15832, Article 15832

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction: When is a mutation not a mutation: the case of the c.594-2AC splice variant in a woman harbouring another BRCA1 mutation in trans

Hereditary cancer in clinical practice, 2022-05, Vol.20 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients

Scientific reports, 2016-09, Vol.6 (1), p.33435-33435, Article 33435

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic insights into breast cancer risk

Hereditary cancer in clinical practice, 2015-09, Vol.13 (S1), p.A1-A1, Article A1

2015

Link zum Volltext

Verfügbarkeit prüfen

The curious case of a woman with two BRCA1 mutations in trans

Hereditary cancer in clinical practice, 2015-11, Vol.13 (S2), p.A11-A11, Article A11

2015

Link zum Volltext

Verfügbarkeit prüfen

When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans

Hereditary cancer in clinical practice, 2016-02, Vol.14 (1), p.6, Article 6

2016

Link zum Volltext

Verfügbarkeit prüfen

When is a mutation not a mutation: the case of the c.594-2AC splice variant in a woman harbouring another BRCA1 mutation in trans

Hereditary cancer in clinical practice, 2016-02, Vol.14 (6)

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

BCL-2 family isoforms in apoptosis and cancer

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer

Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy

Methyl-Donor and Cofactor Nutrient Intakes in the First 2-3 Years and Global DNA Methylation at Age 4: A Prospective Cohort Study

Low prevalence of germline PALB2 mutations in Australian triple‐negative breast cancer

Global DNA methylation and cognitive and behavioral outcomes at 4 years of age: A cross‐sectional study

Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study

Mutations in RECQL are not associated with breast cancer risk in an Australian population

The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome

Fusobacterium nucleatum : An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context

Reevaluation of RINT1 as a breast cancer predisposition gene

Correction: When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015

Novel genes associated with lymph node metastasis in triple negative breast cancer

Correction: When is a mutation not a mutation: the case of the c.594-2AC splice variant in a woman harbouring another BRCA1 mutation in trans

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients

Genetic insights into breast cancer risk

The curious case of a woman with two BRCA1 mutations in trans

When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans

When is a mutation not a mutation: the case of the c.594-2AC splice variant in a woman harbouring another BRCA1 mutation in trans

Suchergebnisse filtern